annual cash & cash equivalents:
$156.32M+$23.00M(+17.26%)Summary
- As of today (August 29, 2025), ABCL annual cash & cash equivalents is $156.32 million, with the most recent change of +$23.00 million (+17.26%) on December 31, 2024.
- During the last 3 years, ABCL annual cash & cash equivalents has fallen by -$319.82 million (-67.17%).
- ABCL annual cash & cash equivalents is now -73.69% below its all-time high of $594.12 million, reached on December 31, 2020.
Performance
ABCL Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$578.08M-$52.19M(-8.28%)Summary
- As of today (August 29, 2025), ABCL quarterly cash & cash equivalents is $578.08 million, with the most recent change of -$52.19 million (-8.28%) on June 1, 2025.
- Over the past year, ABCL quarterly cash & cash equivalents has dropped by -$117.28 million (-16.87%).
- ABCL quarterly cash & cash equivalents is now -44.80% below its all-time high of $1.05 billion, reached on June 30, 2022.
Performance
ABCL quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ABCL Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.3% | -16.9% |
| 3 y3 years | -67.2% | -44.8% |
| 5 y5 years | +1969.7% | +410.9% |
ABCL Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.2% | +17.3% | -44.8% | at low |
| 5 y | 5-year | -73.7% | +1969.7% | -44.8% | +534.7% |
| alltime | all time | -73.7% | +1969.7% | -44.8% | +7553.6% |
ABCL Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $578.08M(-8.3%) |
| Mar 2025 | - | $630.27M(-3.4%) |
| Dec 2024 | $156.32M(+17.3%) | $652.71M(-2.3%) |
| Sep 2024 | - | $668.14M(-3.9%) |
| Jun 2024 | - | $695.36M(-3.8%) |
| Mar 2024 | - | $723.02M(-8.2%) |
| Dec 2023 | $133.32M(-65.5%) | $787.18M(-2.9%) |
| Sep 2023 | - | $810.84M(-1.2%) |
| Jun 2023 | - | $820.69M(-0.1%) |
| Mar 2023 | - | $821.50M(-10.1%) |
| Dec 2022 | $386.54M | $913.68M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $893.21M(-14.7%) |
| Jun 2022 | - | $1.05B(+29.1%) |
| Mar 2022 | - | $811.05M(+8.4%) |
| Dec 2021 | $476.14M(-19.9%) | $747.98M(-0.7%) |
| Sep 2021 | - | $753.48M(-4.9%) |
| Jun 2021 | - | $792.57M(+15.6%) |
| Mar 2021 | - | $685.79M(+15.4%) |
| Dec 2020 | $594.12M(+7766.0%) | $594.12M(+552.3%) |
| Sep 2020 | - | $91.08M(-19.5%) |
| Jun 2020 | - | $113.14M(+1397.9%) |
| Dec 2019 | $7.55M(-27.7%) | $7.55M |
| Dec 2018 | $10.44M | - |
FAQ
- What is AbCellera Biologics Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual cash & cash equivalents year-on-year change?
- What is AbCellera Biologics Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly cash & cash equivalents year-on-year change?
What is AbCellera Biologics Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of ABCL is $156.32M
What is the all time high annual cash & cash equivalents for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual cash & cash equivalents is $594.12M
What is AbCellera Biologics Inc. annual cash & cash equivalents year-on-year change?
Over the past year, ABCL annual cash & cash equivalents has changed by +$23.00M (+17.26%)
What is AbCellera Biologics Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ABCL is $578.08M
What is the all time high quarterly cash & cash equivalents for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly cash & cash equivalents is $1.05B
What is AbCellera Biologics Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, ABCL quarterly cash & cash equivalents has changed by -$117.28M (-16.87%)